Silvercrest Asset Management Group LLC Ligand Pharmaceuticals Inc Transaction History

Silvercrest Asset Management Group LLC

  • $14.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$63.37 - $107.88 $2.54 Million - $4.33 Million
-40,151 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $1.15 Million - $1.35 Million
-11,852 Reduced 22.79%
40,151 $4.19 Million
Q3 2019

Nov 14, 2019
BUY
$86.25 - $120.16 $4.49 Million - $6.25 Million
52,003 New
52,003 $5.18 Million

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email